Energy News / Shareholders Foundation, Inc.

NASDAQ: HSDT Shareholder Notice: Investigation of Potential Wrongdoing at Helius Medical Technologies, Inc.

Via: ReleaseWire

Updated 12:15 PM CST, Thu, December 05,2019

An investigation on behalf of current long term investors in Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares over possible breaches of fiduciary duty by certain officers and directors was announced and NASDAQ: HSDT stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 12/05/2019 -- An investigation was announced for current long-term investors in shares of Helius Medical Technologies, Inc. (NASDAQ: HSDT) concerning potential breaches of fiduciary duties by certain directors of Helius Medical Technologies, Inc..

Investors who are current long term investors in Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for investors in NASDAQ: HSDT stocks follows a lawsuit filed against Helius Medical Technologies, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: HSDT stocks, concerns whether certain Helius Medical Technologies, Inc. directors are liable in connection with the allegations made in that lawsuit.

The plaintiff alleges that the Defendants failed to disclose to investors: (1) that the clinical study on the use of PoNS did not produce statistically significant results regarding the effectiveness of the treatment; (2) that, as a result, the clinical study did not support the Company's application for regulatory clearance; (3) that, as a result, the Company was unlikely to receive regulatory approval of PoNS; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Helius Medical Technologies, Inc. (NASDAQ: HSDT) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaq-hsdt-shareholder-notice-investigation-of-potential-wrongdoing-at-helius-medical-technologies-inc-1267210.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com